Healthy Skepticism Library item: 2568
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Consumers ASSOCIATION, .
dtca alliances organisations
2001;
Abstract:
This report concludes that there is an urgent need for the UK government to undertake a proper analysis of the implications of allowing drug companies more freedom to promote their products directly to patients. Current deliberations at the UK and EU policy level are dominated by the pharmaceutical industry’s perspective. If this debate is not expanded to include a full assessment of this issue from the patient and public perspective, the UK may well see the introduction of DTCA with potentially disastrous consequences for patients, the wider public and the NHS.
Keywords:
*analysis
United Kingdom
United States
DTCA
direct-to-consumer advertising
NHS
National Health Service
consumer drug prices
attitude toward promotion
quality of prescribing
quality of information
ATTITUDES REGARDING PROMOTION: CONSUMERS
PATIENTS
EVALUATION OF PROMOTION: DIRECT-TO-CONSUMER ADVERTISING
INFLUENCE OF PROMOTION: CONSUMER DRUG COSTS
INFLUENCE OF PROMOTION: CONSUMERS AND PATIENTS
INFLUENCE OF PROMOTION: PRESCRIBING, DRUG USE
PROMOTION AS A SOURCE OF INFORMATION: CONSUMERS AND PATIENTS
PROMOTIONAL TECHNIQUES: ENDORSEMENTS
